CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics - ScienceDirect
Por um escritor misterioso
Descrição
Frontiers A Review of Pharmacology, Toxicity and Pharmacokinetics of 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-Glucoside
PDF) Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine
CRISPR-Cas9: A New Addition to the Drug Metabolism and Disposition Tool Box
Xenograft and organoid model systems in cancer research
Brain organoid: a 3D technology for investigating cellular composition and interactions in human neurological development and disease models in vitro, Stem Cell Research & Therapy
CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics - ScienceDirect
Oncology Mouse Models: How to Pick the Right Mouse Model for Your Oncology Drug Development Needs?
Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury - Journal of Pharmaceutical Sciences
Methods of CRISPR/Cas9 technology to construct animal models. (A)
Human and mouse artificial chromosome technologies for studies of pharmacokinetics and toxicokinetics - ScienceDirect
Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats - Journal of Molecular and Cellular Cardiology
Drug approval prediction based on the discrepancy in gene perturbation effects between cells and humans - eBioMedicine
Frontiers Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
CRISPR/Cas9-Mediated miR-29b Editing as a Treatment of Different Types of Muscle Atrophy in Mice: Molecular Therapy
Emerging therapies for Duchenne muscular dystrophy - The Lancet Neurology
